PopVax is an Indian biotechnology company based in Hyderabad, with a primarily remote US subsidiary nominally based in New York. We are funded via research agreements with the Gates Foundation and Vitalik Buterin’s biosecurity company Balvi. For the past year, we have been building a novel second-generation mRNA platform for low-cost broadly-protective vaccines via computationally-driven antigen design, starting with an open-source booster vaccine candidate that is intended to protect against the entire sarbecovirus species and, if things go well, the betacoronavirus genus, including current and future strains of SARS-CoV-2, the virus which causes COVID-19.

We’re looking for a procurement executive to join our procurement team, reporting to the Senior Manager - Procurement.

RESPONSIBILITIES

• Purchase of materials for R&D, including liaison with R&D personnel to understand the requirements, identify vendors, negotiate rates, place orders and monitor deliveries

•  Customs clearance of imported materials including documentation and liaison with the CHA

• Coordinate with PopVax Operations department to source and purchase machinery and specialized equipment

QUALIFICATIONS

• 2-3 years of experience highly preferred in sourcing a wide range of pharmaceutical materials, including biological materials like enzymes and other reagents, as well as instruments and specialized equipment (with a particular emphasis on GMP-grade materials)

• Experience dealing with small and large local and multinational vendors with proven negotiation skills and commercial acumen

• Well versed with customs clearance procedures for imports

• Familiarity with  logistics of materials supply, especially international freight forwarding of temperature sensitive materials

• Knowledge of ERP systems like SAP for purchase activities is a plus

• Good oral and written communication skills with the ability to work with multifunctional teams

We offer very competitive compensation, comprehensive health insurance covering immediate family (including pre-existing conditions), and, most importantly, a collaborative work environment focused on solving the cutting-edge multidisciplinary challenges of our novel mRNA platform.